share_log

Galera Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sofinnova Venture Partners IX, L.P. (“SVP IX”)(0.0%),Sofinnova Management IX, L.L.C. (“SM IX”)(0.0%), etc.

SEC announcement ·  Feb 20 18:59
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more